Blue Matter
Blue Matter is a strategic consulting firm serving the life sciences industry, specializing in pharmaceutical and biotech sectors. Founded in 2012, it aims to bring a new approach to consulting with original ideas that deliver meaningful impact. The firm empowers life sciences companies to achieve their full potential through strategy and commercialization support, with a client base including over 250 companies from start-ups to top global biopharma firms. Blue Matter combines the tools and methodologies of a large global consulting firm with personalized service and creativity, focusing on innovation, industry trends, and technological advancements.
Industries
Nr. of Employees
medium (51-250)
Blue Matter
San Francisco, CA, USA
Products
Industry whitepapers and research reports
Published whitepapers, study reports, and eBooks covering topics such as RWE, decision science, go-to-market performance, medical affairs best practices, and regional market entry.
Industry whitepapers and research reports
Published whitepapers, study reports, and eBooks covering topics such as RWE, decision science, go-to-market performance, medical affairs best practices, and regional market entry.
Services
Advisory engagements to define product-level, portfolio-level, and corporate strategy for life sciences companies.
Services for launch readiness, commercial planning, and go-to-market execution to maximize launch performance.
Development of pricing, reimbursement, and payer engagement strategies to support market access.
Design of medical affairs organizations and real-world evidence generation strategies to support clinical and commercial goals.
Quantitative modeling, decision frameworks, and analytics to inform portfolio and product decisions.
Primary and secondary research, segmentation, forecasting, and commercial analytics to support strategy.
Advisory engagements to define product-level, portfolio-level, and corporate strategy for life sciences companies.
Services for launch readiness, commercial planning, and go-to-market execution to maximize launch performance.
Development of pricing, reimbursement, and payer engagement strategies to support market access.
Design of medical affairs organizations and real-world evidence generation strategies to support clinical and commercial goals.
Quantitative modeling, decision frameworks, and analytics to inform portfolio and product decisions.
Primary and secondary research, segmentation, forecasting, and commercial analytics to support strategy.
Expertise Areas
- Commercial and launch strategy
- Medical Affairs and real-world evidence (RWE)
- Market access and HEOR
- Decision science and quantitative modeling
Key Technologies
- Real-world evidence (RWE) analysis
- Health economics and outcomes research (HEOR)
- Decision-science models and quantitative frameworks
- Commercial data analytics and forecasting